•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A03963 Summary:

BILL NOA03963
 
SAME ASNo Same As
 
SPONSORMcDonald
 
COSPNSR
 
MLTSPNSR
 
Amd §3306, Pub Health L
 
Includes sleep medication Suvorexant in the Schedule IV list of depressant drugs.
Go to top    

A03963 Actions:

BILL NOA03963
 
01/30/2025referred to health
01/07/2026referred to health
Go to top

A03963 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A3963
 
SPONSOR: McDonald
  TITLE OF BILL: An act to amend the public health law, in relation to including Suvorex- ant in the Schedule IV list of depressant drugs   PURPOSE:: To add Suvorexant to the NYS list' of Schedule IV controlled substances to align with the federal regulations.   SUMMARY OF PROVISIONS:: Section 1 amends subsection (c) of schedule IV of section 3306 of the 2 public health law by adding a new paragraph 54 Section 2 establishes the effective date.   JUSTIFICATION: Suvorexant is a pharmaceutical that is Food and Drug Administration (FDA) approved and a Drug Enforcement Agency ,(DEA) scheduled controlled substance that is not included in the New York State Prescription Moni- toring Program (PMP). This legislation would add Suvorexant to the PMP which is an important tool for practitioners when prescribing Schedule II, III, and IV controlled substances. The PMP Registry provides practi- tioners with direct, secure access to view dispensed controlled substance prescription histories for their patients.   LEGISLATIVE HISTORY:: New Bill   FISCAL IMPLICATIONS:: None   EFFECTIVE DATE:: This act shall take effect on the ninetieth day after it shall have become a law.
Go to top

A03963 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          3963
 
                               2025-2026 Regular Sessions
 
                   IN ASSEMBLY
 
                                    January 30, 2025
                                       ___________
 
        Introduced by M. of A. McDONALD -- read once and referred to the Commit-
          tee on Health
 
        AN ACT to amend the public health law, in relation to including Suvorex-
          ant in the Schedule IV list of depressant drugs
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Subdivision (c) of schedule  IV  of  section  3306  of  the
     2  public  health  law  is  amended by adding a new paragraph 54 to read as
     3  follows:
     4    (54) Suvorexant.
     5    § 2. This act shall take effect on the ninetieth day  after  it  shall
     6  have become a law.
 
 
 
 
 
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD07509-01-5
Go to top